A preferable signature of gut microbiota and bile acids predicted better outcomes of unresectable hepatocellular carcinoma to immune checkpoint inhibitors

被引：0
|
作者：
Lee, Pei-Chang [1 ]
Wu, Chijung [1 ]
Hung, Ya-Wen [1 ]
Lee, ChiehJu [1 ]
Chi, Chen-Ta [1 ]
Lee, I-Cheng [1 ]
Luo, Jiing-Chyuan [1 ]
Hou, Ming-Chih [1 ]
Huang, Yi-Hsiang [1 ]
机构：
[1] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OS160
引用
收藏
页码：S109 / S110
页数：2
相关论文
共 50 条
  • [11] Perspective on the Role of Gut Microbiome in the Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors
    Abenavoli, Ludovico
    Montori, Michele
    Baroni, Gianluca Svegliati
    Argenziano, Maria Eva
    Giorgi, Francesca
    Scarlata, Giuseppe Guido Maria
    Ponziani, Francesca
    Scarpellini, Emidio
    MEDICINA-LITHUANIA, 2023, 59 (08):
  • [12] Clinical Outcomes in Fibrolamellar Hepatocellular Carcinoma Treated with Immune Checkpoint Inhibitors
    Chen, Krista Y.
    Popovic, Aleksandra
    Hsiehchen, David
    Baretti, Marina
    Griffith, Paige
    Bista, Ranjan
    Baghdadi, Azarakhsh
    Kamel, Ihab R.
    Simon, Sanford M.
    Migler, Rachael D.
    Yarchoan, Mark
    CANCERS, 2022, 14 (21)
  • [13] Low-Level Viremia Impairs Efficacy of Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma
    Li, Rong
    Li, Wenli
    Yang, Qing
    Guan, Yujuan
    Chen, Yongru
    Zhu, Peilin
    Su, Kaiyan
    Li, Qi
    Hu, Xiaoyun
    Zang, Mengya
    Zhao, Miaoxian
    Zhong, Manhua
    Yan, Jingquan
    Yang, Keli
    Zhu, Wei
    Lin, Zhanzhou
    Yuan, Guosheng
    Chen, Jinzhang
    LIVER INTERNATIONAL, 2025, 45 (04)
  • [14] Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors
    Rujia Zhang
    Haoran Zhao
    Peng Wang
    Zuoming Guo
    Chunxun Liu
    Zhaowei Qu
    BMC Cancer, 23
  • [15] Lenvatinib plus transarterial chemoembolization with or without immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A review
    Sun, Liwei
    Xu, Xuelong
    Meng, Fanguang
    Liu, Qian
    Wang, Hankang
    Li, Xiaodong
    Li, Guijie
    Chen, Feng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [16] Efficacy and Safety Associated With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma A Meta-analysis
    Jacome, Alexandre A.
    Castro, Ana Carolina G.
    Vasconcelos, Joao Paulo S.
    Silva, Maria Helena C. R.
    Lessa, Marco Antonio O.
    Moraes, Eduardo D.
    Andrade, Aline C.
    Lima, Frederico M. T.
    Farias, Joao Paulo F.
    Gil, Roberto A.
    Prolla, Gabriel
    Garicochea, Bernardo
    JAMA NETWORK OPEN, 2021, 4 (12) : E2136128
  • [17] Hepatocellular carcinoma immune prognosis score predicts the clinical outcomes of hepatocellular carcinoma patients receiving immune checkpoint inhibitors
    Zhang, Rujia
    Zhao, Haoran
    Wang, Peng
    Guo, Zuoming
    Liu, Chunxun
    Qu, Zhaowei
    BMC CANCER, 2023, 23 (01)
  • [18] Characterization of gut microbiota in patients with primary hepatocellular carcinoma received immune checkpoint inhibitors A Chinese population-based study
    Li, Lili
    Ye, Jiajian
    MEDICINE, 2020, 99 (37) : E21788
  • [19] Potential roles of gut microbiome in patients with hepatocellular carcinoma treated with immune checkpoint inhibitors
    Su, Yung-Yeh
    Lee, Wei-Hsiang
    Wang, Jing-Houng
    Wang, Hung-Wei
    Chen, Teng-Wei
    Chen, Bang-Bin
    Ho, Hsiu J.
    Liu, Tsung-Hao
    Chou, Shu-Cheng
    Chen, Bor-Rong
    Liu, Tsang-Wu
    Chen, Li-Tzong
    Wu, Chun-Ying
    Hsu, Chiun
    ANNALS OF ONCOLOGY, 2022, 33 : S484 - S484
  • [20] Transarterial Chemoembolization Combined With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors for Unresectable Hepatocellular Carcinoma: Efficacy and Systemic Immune Response
    Yang, Fei
    Xu, Gui-Li
    Huang, Jin-Tao
    Yin, Yu
    Xiang, Wei
    Zhong, Bin-Yan
    Li, Wan-Ci
    Shen, Jian
    Zhang, Shuai
    Yang, Jun
    Sun, Hong Peng
    Wang, Wan-Sheng
    Zhu, Xiao-Li
    FRONTIERS IN IMMUNOLOGY, 2022, 13
12345